Clinical Trials
2 trialsNCT04504331 2026-02-12
Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast Cancer
Stanford University
Phase 1 Terminated
NCT05754749 2025-09-25
Comparison of CE-DBT and MRI in Patients With Known Breast Lesions
UNC Lineberger Comprehensive Cancer Center
Phase EARLY_PHASE1 Recruiting